Who We Are

The Kidney Innovation Accelerator (KidneyX) is a public-private partnership between the US Department of Health and Human Services (HHS) and the American Society of Nephrology (ASN) to accelerate innovation in the prevention, diagnosis, and treatment of kidney diseases. KidneyX seeks to improve the lives of the 850 million people worldwide currently affected by kidney diseases by accelerating the development of drugs, devices, biologics and other therapies across the spectrum of kidney care including prevention, diagnostics, and treatment.

Building off the success of similar public-private accelerators, KidneyX will engage a community of researchers, innovators, and investors to bring breakthrough therapies to patients through a series of prize competitions. ASN and HHS leaders are overseeing KidneyX's efforts to accelerate the pace of innovation in the development of disruptive approaches to kidney care and the development of new medical products, leading to solutions that will improve the lives of the millions of people worldwide affected by kidney diseases. We hope you will consider joining us in this effort.


John R. Sedor, MD, FASN, ASN Chair

John R. Sedor, MD is the Endowed Chair in Kidney Research at the Glickman Urology & Kidney Institute at Cleveland Clinic, a Professor of Molecular Medicine at Lerner College of Medicine, and a member of the Kidney Disease Research Center and the Departments of Medicine and Physiology and Biophysics at Case Western Reserve University. Dr. Sedor is a graduate of the University of Virginia and the University of Virginia School of Medicine, and completed his residency training and nephrology fellowship at Case Western Reserve University and University Hospitals of Cleveland. Dr. Sedor is board certified in internal medicine and nephrology.

Dr. Sedor is an active physician scientist whose research focuses on progressive kidney disease mechanisms. The overall goal of the lab is to define the clinical, cellular and genetic bases of kidney disease in order to identify new therapies and diagnostic tests. Current projects include identification of human nephropathy susceptibility genes and defining mechanisms of kidney disease progression using in vitro (cell culture) and animal models. Dr. Sedor's clinical interests include consultative nephrology, especially patients with glomerular diseases and progressive chronic kidney disease. He has received numerous honors and awards including the National Kidney Foundation David M. Hume Award and has several times received recognition as one of the Best Doctors in America.

Dr. Sedor has served in many leadership roles at the American Society of Nephrology, including Secretary-Treasurer, Chair of the Research Advocacy Committee, as a member of the Public Policy Board Chair, as Chair of the Program Committee (2007) and Chair of the Ad Hoc Research Policy Committee, 2009-2010, as Associate Editor of NephSAP, Co-Chair of the Organizing Committee, ASN/NIDDK Diabetic Nephropathy Research Retreat, 2004; Member American Society of Nephrology/National Kidney Foundation Joint Task Force on Research, 2002-2004; Chair, Clinical Sciences Committee, (2001-2004); Government Relations Committee 2001-2003.

Ed Simcox, JD, HHS Chief Technology Officer and Acting Chief Information Officer

Ed Simcox is the Chief Technology Officer (CTO) at the U.S. Department of Health and Human Services (HHS). As the CTO at HHS, Ed provides leadership and direction to ensure that HHS effectively leverages data, technology and innovation to improve the lives of the American people and the performance of the operating divisions across the Department. Simcox has been working at the intersection of healthcare and technology for 18 years.

Prior to joining HHS, Simcox served as the Healthcare Practice Leader at Logicalis, an international IT service provider and consultancy with over 300 healthcare clients in the United States. In this role, Simcox led the strategy, solution development, and consulting for the U.S. healthcare sector. He engaged with healthcare providers across the US in a consulting capacity and advocated for the liberation of healthcare data and telehealth adoption.

Prior to joining Logicalis, Ed was director of U.S. healthcare strategy, partnerships, and product development for AT&T. Ed's portfolio included emerging technologies and products supporting mHealth, telehealth, and health information exchange.

Before joining AT&T, Ed held multiple leadership roles at Indiana University Health, a large U.S. healthcare system with 19 hospitals, 50 physician groups and annual revenue of over $6 billion. Simcox served as the Chief Technology Officer, and prior to that, the Director of Business Innovations, an internal innovation incubator and design lab. Simcox was awarded ComputerWorld's Laureate medal for leading a project that achieved $5 million in savings through the design and implementation of innovative IT solutions in the inpatient healthcare setting. During Simcox's time as CTO, Indiana University Health received Hospitals and Health Networks' "Most Wired Hospital" award based in part on his team's work with emerging technologies.